Virus Related Content

Severe cases of inflammation from COVID-19 can occur in some people – leading to cases of acute respiratory distress and multi-organ damage.

Understanding the infection strategy of mosquito-borne viruses known as flaviviruses is key in the future development of treatments and possible vaccines

MedUni Vienna delivers promising data to the Omicron variant vaccine which could protect people against all known variants of the SARS-CoV-2 virus.

Researchers find the best protection against COVID-19 is vaccinations rather than natural immunity, when analysing how infection with SARS-CoV-2 affects the immune system.

Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.

Ivan Toplak, Professor from the University of Ljubljana, Veterinary Faculty, reveals what we know about honeybee viral strains and transmission between honeybee colonies.

The politics of COVID-19 is intertwined with infection rates, where researchers highlight the linear transmission rate in more authoritarian areas.

Climate change is set to rise temperatures globally through greenhouse gas emissions, amidst this change, rates of infectious diseases are to become increasingly difficult to predict.

Reducing the risk of future pandemics takes investment, biodiversity action, and fostering better human-wildlife relationships to prevent the spread of zoonotic viruses.

Despite healthcare workers experiencing the negative effects of the COVID-19 virus, many did not intend on being vaccinated – new research highlights that their outlooks have changed.

Researchers developed a simulation model for schools during the pandemic, identifying what schools need to do to minimise COVID cases.

The human immune system is an intricate web designed to stop invading pathogens - but with over 200 virus species capable of infecting humans, some have a way to break through.

Research demonstrates the ability to prevent COVID-19 from entering human cells through cannabinoid acids binding to a SARS-CoV-2 protein, blocking infection from the virus.

Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field

Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.

New research analyses mutation types occurring in the Coronavirus after infection in cats, dogs, ferrets, and hamsters, studying cross-species transmission in animals.

A device created to identify viruses in humans, like COVID-19, has sustained 95% accuracy in results, as a significant improvement over the current rapid tests available.

Zisis Kozlakidis and Dewi Nur Aisyah, explain the renewed focus on resource-restricted settings when it comes to COVID-19 infection prevention

A new study focuses on HIV data in sub-Saharan Africa, analysing the number of people living with HIV in 47 countries, the population distribution, and the locations of healthcare facilities.

Compassion in World Farming Research Manager dissects some of the dangers of the factory farming industry, discussing the spread of zoonotic diseases.